- New Guideline: Therapeutic Use of Medical Cannabis in New York State (1/25/22)
- Topics, Trends & Updates for January (1/13/22)
- Updated: COVID-19 Vaccine for Adults With HIV (1/12/22)
- Updated: Perioperative Care in Adults With HIV (11/16/21)
- Updated: Selecting An Initial ART Regimen (10/11/21)
- Updated: When to Initiate ART, With Protocol for Rapid Initiation (10/11/21)
- Updated: Diagnosis and Management of HIV-2 in Adults (10/11/21)
- Medscape Interviews Dr. Elliot DeHaan, Lead Author of New Guideline on CAB/RPV LA (8/3/21)
- Medscape Commentary: IRIS: 'Why Is My Patient Getting Worse?' (7/29/21)
- Updated Resource: ART Drug-Drug Interactions (7/20/21)
- Updated Guideline: Diagnosis and Management of Acute HIV Infection (7/20/21)
- New Guideline: Substance Use Disorder Treatment in Pregnant Adults (7/16/21)
- New Guideline: Use of Injectable CAB/RPV LA as Replacement ART in Virally Suppressed Adults (7/14/21)
- New Recommendation: COVID-19 Vaccine for Adults With HIV (7/13/21)
- Updated Guideline: Laboratory Monitoring for Adverse Effects of ART (6/8/21)
- Updated: Use of Dolutegravir in Individuals of Childbearing Capacity (6/3/21)
- Updated Guideline: Prevention and Management of Hepatitis A Virus in Adults With HIV (5/21/21)
- Medscape Commentary: A Framework for Comprehensive HIV Primary Care (5/19/21)
- What We're Reading: Weight Gain Associated With TAF (5/6/21)
- Updated Guideline: Management of IRIS (4/28/21)
- Updated: ART Drug-Drug Interactions Guide (2/26/21)
- Medscape Commentary: The Vanguard of HIV Care: Don't Forget This Screening (2/23/21)
- New Guideline: Comprehensive Primary Care for Adults With HIV (2/9/21)
- Remembering Dr. John G. Bartlett (1/25/21)
- Guidance: Adolescent Consent to HIV and STI Treatment and Prevention (1/6/21)
- FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant (1/24/22)
- FDA Takes Actions to Expand Use of Treatment for Outpatients with Mild-to-Moderate COVID-19 (1/21/22)
- Free At-Home COVID-19 Tests (1/19/22)
- FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months (1/7/22)
- FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine (1/3/22)
- NYCDOHMH: mRNA COVID-19 Vaccines Preferred Over Johnson & Johnson (12/23/21)
- FDA EUA for Paxlovid for COVID-19 (12/23/21)
- NYCDOHMH: COVID-19 Boosters Recommended for People Ages 16 and 17 Years (12/16/21)
- FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Booster Dose to 16- and 17-Year-Olds (12/9/21)
- NYCDOHMH: CDC Recommends All Adults May Receive a COVID-19 Booster Dose (11/24/21)
- NYCDOHMH: Update on COVID-19 Vaccine Booster Doses (11/13/21)
- NYCDOHMH: CDC Recommends Pfizer COVID-19 Vaccine for Children Ages 5 to 11 Years (11/6/21)
- FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age (10/29/21)
- NYCDOHMH: CDC Recommends COVID-19 Vaccine Boosters for Johnson & Johnson and Moderna Recipients (10/23/21)
- NYCDOHMH: Booster Dose for Pfizer-BioNTech COVID-19 Vaccine (9/28/21)
- FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for Certain Populations (9/22/21)
- FDA Approves First COVID-19 Vaccine (8/23/21)
- NYCDOHMH: COVID-19 Monoclonal Antibody Treatment Updates for the Outpatient Setting (8/21/21)
- Q/A: Why Are Vaccines and Masks Needed for Protection During the COVID-19 Pandemic? (8/17/21)
- NYCDOHMH: Guillain-Barre Syndrome After J&J COVID-19 Vaccine and Additional Doses (8/3/21)
- NYCDOHMH: Dear Colleague COVID-19 Updates, COVID-19 Vaccination: Fertility, Pregnancy and Postpartum (7/28/21)
- New Recommendation: COVID-19 Vaccine for Adults With HIV (7/13/21)
- NYCDOHMH: COVID-19 Vaccine Updates: Johnson & Johnson/Janssen and People Vaccinated Outside the US (5/22/21)
- NYCDOHMH: COVID-19 Vaccine for Adolescents and Co-administration (5/19/21)
- NYCDOHMH: COVID-19 Vaccine Appointment Scheduling Resources and Information (4/13/21)
- HIVinfo: Updated Resources Available: HIV and Opportunistic Infections, Coinfections, and Conditions (1/26/22)
- HIVinfo: Updates to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV (1/24/22)
- HIVinfo: Updated Resources Available: Living with HIV and HIV and Specific Populations (1/21/22)
- AETC NCRC: January 2022 Monthly Update (1/19/22)
- CEI Newsletter (1/18/22)
- NYS Medicaid Update (1/6/22)
- HIVinfo: Updates to Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the US (12/30/21)
- FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention (12/20/2021)
- FDA: Possible False RPR Reactivity with BioPlex 2200 Syphilis Total & RPR Test Kit Following a COVID-19 Vaccine (12/20/21)
- HIVinfo: Updated Resources Available: The Basics of HIV and AIDS and HIV Prevention (12/16/21)
- NYSDOH AI: HCV Testing in Pregnant Persons Dear Colleague Letter (11/3/21)
- HIVinfo: New HIV Source Web Portal (10/29/21)
- PrEP Aware Week 2021: More to Learn (10/29/21)
- HIVinfo Updated Fact Sheets on HIV and Lipodystrophy, HIV and Older People, HIV and Hepatitis C (9/23/21)
- PrEP Aware Week -- Save the Dates: October 25 to 31 (9/17/20)
- HIVinfo Updated Fact Sheets on HIV and Pregnancy (9/9/21)
- NYSDOH Health Advisory: Increased Number of HIV Diagnoses in Erie and Monroe Counties (8/30/17)
- HHS: Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV: Human Papillomavirus Disease (8/18/21)
- HHS: Updates to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV: Hepatitis C Virus/HIV Coinfection (8/16/21)
- Health Equity Competencies for Health Care Providers (8/5/2021)
- CDC’s Sexually Transmitted Infections Treatment Guidelines Update (7/27/21)
- NASTAD PrEP Coverage Brief: PrEP Services Covered with No Cost-Sharing (7/26/21)
- NYC Health: Free CME on Latent Tuberculosis Infection (6/9/21)
- Syracuse University Aging Studies Institute: HIV+ Aging and Long-Term Survivors 2021 Survey (6/9/21)
- HHS: Updates to the Antiretroviral Agents in Adults and Adolescents Living with HIV Guidelines Released (6/3/21)
- 01/27/2022: HCV and Drug User Health COE ECHO: Clinical Approaches to Medical Cannabis
- 02/02/2022: HIV Primary Care and Prevention COE ECHO: Anal Dysplasia and Cancer for People Living with HIV
- 02/09/2022: Sexual Health COE ECHO: Syphilis Testing: What’s New in the Laboratory?
- 02/22/2022: HepCure & HCV and Drug User Health COE: Hepatitis C Treatment
- 03/07/2022: HIV Primary Care and Prevention COE: HIV and COVID-19
- 03/09/2022: HCV and Drug User Health COE: X-Express: Buprenorphine Prescribing for Beginners
- 03/14/2022: Sexual Health COE: Lunch & Learn Series: Delabeling Penicillin Allergy
- 01/27/2022: 2022 National Black HIV/AIDS Awareness Day webinar/Town Hall Discussion
- 01/28/2022: MATEC: HIV Care & Oral Health – An Update
- 02/02/2022: NYS Hepatitis C Elimination Virtual Regional Discussion Session: Western NY Region
- 02/09/2022: NYS Hepatitis C Elimination Virtual Regional Discussion Session: Northeastern Region
- 02/11/2022: 9th Annual Rural HIV Research & Training Conference
- 02/11/2022: MA AETC: Motivational Interviewing
- 02/12/2022: CROI 2022
- 02/14/2022: NEAETC: Pain Management in Individuals with HIV: Challenges and Opportunities
- 02/17/2022: NYS Hepatitis C Elimination Virtual Regional Discussion Session: Central NY Region
- 02/23/2022: NYS Hepatitis C Elimination Virtual Regional Discussion Session: Finger Lakes Region
- 02/23/2022: NEAETC: Mental Health and HIV
- 02/24/2022: NYS Hepatitis C Elimination Virtual Regional Discussion Session: Hudson Valley Region
- 02/24/2022: MATEC: HIV Immunopathology and HIV Screening/Testing
- 02/28/2022: NYS Hepatitis C Elimination Virtual Regional Discussion Session: Long Island
- 03/03/2022: NYS Hepatitis C Elimination Virtual Regional Discussion Session: New York City
- 03/07/2022: NEAETC: CROI Update 2022
- 03/14/2022: MATEC: Clinical Manifestations of HIV/AIDS and Opportunistic Infections
- 03/24/2022: SCAETC: National Latinx Conference on HIV, HCV, & SUD
- 03/24/2022: MATEC: Living Well with HIV
- 04/20/2022: NEAETC: New PrEP Guidelines
- 05/05/2022: ACTHIV 2022
- 06/08/2022: Indiana University National HIV Conference
- 07/29/2022: AIDS 2022 (The 24th International AIDS Conference)
- 08/23/2022: HRSA: National Ryan White Conference on HIV Care & Treatment